Accelerating research

and development of

new antibiotics and

alternatives

The Netherlands Antibiotic Development Platform

The Netherlands Antibiotic Development Platform (NADP) facilitates the collaboration between public and private organisations, to enhance the development of new antibiotics and alternative therapies for infectious diseases in humans and animals.

NADP will identify relevant research groups, institutes and companies involved in chemical, biological, and/or biomedical antibiotic research to forge collaborations through targeted connections and will organise regular meetings with interested parties. At a later stage, the NADP will provide Drug Discovery Management support/vouchers and Intellectual Property and Technology Transfer Office support.

News

World Antibiotics Awareness Week

World Antibiotic Awareness Week

The week of 13 -19 November 2017 is World Antibiotic Awareness Week! The World Antibiotic Awareness Week is an initiative of the WHO to spread awareness on risks and prevention of antibiotic resistance. For this occasion, an expert panel from the European Academy of Microbiology (EAM) discusses what the future holds for antimicrobial resistance (AMR) and what can be done to actively tackle it.

Read more

WHO: stop using antibiotics in healthy animals to prevent the spread of antibiotic resistance

WHO is recommending that farmers and the food industry stop using antibiotics routinely to promote growth and prevent disease in healthy animals.

The new WHO recommendations aim to help preserve the effectiveness of antibiotics that are important for human medicine by reducing their unnecessary use in animals. In some countries, approximately 80% of total consumption of medically important antibiotics is in the animal sector, largely for growth promotion in healthy animals.

Read more

Upcoming events

A list of upcoming events, with topics around antimicrobial resistance, development of new antibiotics and alternative therapies.

Read more

Funding Opportunities

A list of funding opportunities, with topics around antimicrobial resistance, development of new antibiotics and alternative therapies.

Read more

NADP Partners

CARES-Logo-150x82
CeSAM-logo-147x82
ImmunoValley-logo-210x82
NCOH-logo-210x82

Supported by

Ministerie-VWS